SRPT — Sarepta Therapeutics, Inc. stock price, charts and financials

QT36Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.39
+0.51+3.21%
OverviewShort InterestFilings
SRPTQT36Sarepta Therapeutics, Inc.·NASDAQ
16.39+3.21%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 30, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20263Initial statement of beneficial ownership
Jul 28, 2026S-8Registration of employee benefit securities
Jul 27, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 04, 2026S-8Registration of employee benefit securities
May 13, 202613F-HRInstitutional investment manager holdings report
May 06, 20268-KCurrent report
May 06, 202610-QQuarterly report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 2026ARSAnnual report to shareholders
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 24, 2026DEFA14AAdditional proxy soliciting materials
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 300
Page
▼
/ 12